Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
9.42
+0.09 (0.96%)
At close: Nov 21, 2024, 4:00 PM
9.50
+0.08 (0.85%)
After-hours: Nov 21, 2024, 6:52 PM EST
Immunome Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 588 | 457 | 27 | 157 | 102 | - | |
| Market Cap Growth | 761.70% | 1605.70% | -82.91% | 53.68% | - | - | |
| Enterprise Value | 351 | 367 | -0 | 101 | 151 | - | |
| Last Close Price | 9.42 | 10.70 | 2.21 | 12.96 | 9.68 | - | |
| PS Ratio | 49.87 | 32.62 | - | - | - | - | |
| PB Ratio | 2.65 | 3.81 | 1.61 | 3.25 | 2.47 | - | |
| P/TBV Ratio | 4.09 | 3.81 | 1.61 | 3.25 | 2.47 | - | |
| EV/Sales Ratio | 34.61 | 26.17 | - | - | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | - | 0.01 | 0.17 | |
| Asset Turnover | 0.06 | 0.16 | - | - | - | - | |
| Quick Ratio | 6.07 | 6.53 | 2.89 | 5.50 | 13.37 | 1.53 | |
| Current Ratio | 6.17 | 6.63 | 3.09 | 5.82 | 14.12 | 1.88 | |
| Return on Equity (ROE) | -276.36% | -156.45% | -113.81% | -55.20% | -79.97% | -374.87% | |
| Return on Assets (ROA) | -39.89% | -20.81% | -56.27% | -30.75% | -30.91% | -136.04% | |
| Return on Capital (ROIC) | -62.32% | -25.93% | -70.82% | -34.95% | -33.47% | -176.90% | |
| Earnings Yield | -51.93% | -23.36% | -137.65% | -15.76% | -17.48% | - | |
| FCF Yield | -23.59% | -1.84% | -107.96% | -11.67% | -12.47% | - | |
| Buyback Yield / Dilution | -340.37% | -63.64% | -5.10% | -240.41% | -209.85% | -0.66% | |
| Total Shareholder Return | -340.37% | -63.64% | -5.10% | -240.41% | -209.85% | -0.66% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.